The patient will be the focus during the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), Collective Wisdom: The Future of Patient-Centered Care and Research.
The patient will be the focus during the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), Collective Wisdom: The Future of Patient-Centered Care and Research. The meeting, being held June 3-7, 2016, at the McCormick Place in Chicago, Illinois, has nearly 30 tracks for attendees to choose from. Registrants can attend clinical sessions that delve into specific tumor types or choose to attend presentations or posters that evaluate care delivery and practice management, ethics in clinical practice, or value of care.
The American Journal of Managed Care will be covering the annual meeting of ASCO. You can sign up to receive daily updates from the meeting at: http://bit.ly/1sSUphW or visit the conference page here: http://bit.ly/1sCduEq.
The following is a glimpse into some of the exciting sessions and research that will be presented this year:
1. Clinical pathways in oncology. Clinical pathways are viewed by health systems and by health plans as a means to standardize oncology care while controlling costs. On the first day of the meeting, the session “Practicing in the Age of Value-Based Clinical Pathways” will provide an overview of the existing landscape of pathway use in the clinic, assess the value that they present, and how they could be integrated into payment reform.
Presenters at the session include oncologists and payers, including Robin Zon, MD, FACP, FASCO, who provided the oncologist’s perspective on pathways in the April issue of Evidence-Based Oncology (EBO).
2. Combination immunotherapies. Several trials are evaluating combination treatments with multiple checkpoint inhibitors, in solid as well as liquid tumors. There’s also a lot of excitement around CAR-T cell therapy in cancer. Presentations during “The View Beyond Single-Agent Checkpoint Blockade” will provide the latest results from clinical trials that are assessing:
3. Facing the burden of paying for care. Health policy researchers, who are also practicing oncologists, will detail the range of financial toxicities that patients being treated for cancer, and their families, face. During the session “Financial Toxicity: Risks, Outcomes, and Solutions,” experts from Columbia University and Duke University will also discuss the impact it has on the lives of patients, while exploring potential solutions. The session will be led by Veena Shankaran, MD, MS, who authored an article on the topic in the December 2015 issue of EBO.
4. Quest for biomarkers with immunotherapy. Although the checkpoint inhibitors have been hailed as revolutionary with respect to outcomes in patients who do respond, identifying a biomarker to choose positive responders has eluded researchers. Progress in the field will be discussed during the clinical session “Immunotherapy: Now We're Getting Personal—Using Genomics and Biomarkers to Predict Response.”
5. Ensuring quality and value in the clinic. As ASCO fine tunes its Value Framework to make it ready for use in the clinic, a panel at the annual meeting, “Quality and Value: Measuring and Utilizing Both in Your Practice” will discuss ways in which providers can adjust the framework and make it operational in the clinic, work with all stakeholders to implement the framework across systems, and also understand how feedback reporting and pay-for-performance initiatives can improve the quality of care.
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More